Flotek Industries (FTK) 10-Q 12 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	Jun. 10, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Transition Report	false
Entity File Number	1-13270
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0023731
Entity Address, Address Line One	8846 N. Sam Houston Parkway W.
Entity Address, City or Town	Houston,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77064
City Area Code	713
Local Phone Number	849-9911
Title of 12(b) security	Common Stock, $0.0001 par value
Trading symbol	FTK
Security exchange name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		70,430,586
Entity Registrant Name	FLOTEK INDUSTRIES INC/CN
Entity Central Index Key	0000928054
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Amendment Flag	false

Unaudited Condensed Consolidate

Unaudited Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 80,263,000	$ 100,575,000
Restricted cash	664,000	663,000
Accounts receivable, net of allowance for doubtful accounts of $1,642 and $1,527 at March 31, 2020 and December 31, 2019, respectively	13,297,000	15,638,000
Inventories, net	16,322,000	23,210,000
Income taxes receivable	6,635,000	631,000
Other current assets	9,005,000	13,191,000
Total current assets	126,186,000	153,908,000
Property and equipment, net	7,946,000	39,829,000
Operating lease right-of-use assets	2,473,000	16,388,000
Deferred tax assets, net	169,000	152,000
Other intangible assets, net	0	20,323,000
TOTAL ASSETS	136,774,000	230,600,000
Current liabilities:
Accounts payable	8,556,000	16,231,000
Accrued liabilities	8,320,000	24,552,000
Income taxes payable	72,000	0
Current portion of operating lease liabilities	1,167,000	486,000
Current portion of finance lease liabilities	56,000	55,000
Total current liabilities	18,171,000	41,324,000
Long-term operating lease liabilities	9,754,000	16,973,000
Long-term finance lease liabilities	144,000	158,000
Deferred tax liabilities, net	0	116,000
Total liabilities	28,069,000	58,571,000
Commitments and contingencies “See Note 16”
Stockholders’ equity:
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.0001 par value, 80,000,000 shares authorized; 64,338,087 shares issued and 59,942,270 shares outstanding at March 31, 2020; 63,656,897 shares issued and 59,511,416 shares outstanding at December 31, 2019	6,000	6,000
Additional paid-in capital	348,375,000	347,564,000
Accumulated other comprehensive loss	(1,089,000)	(966,000)
Retained earnings (accumulated deficit)	(205,058,000)	(141,091,000)
Treasury stock, at cost; 4,395,817 and 4,145,481 shares at March 31, 2020 and December 31, 2019, respectively	(33,529,000)	(33,484,000)
Total stockholders’ equity	108,705,000	172,029,000
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 136,774,000	$ 230,600,000

Unaudited Condensed Consolida_2

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 1,642	$ 1,527
Preferred stock, at par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	100,000	100,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	80,000,000	80,000,000
Common stock, shares issued (in shares)	64,338,087	63,656,897
Common stock, shares outstanding (in shares)	59,942,270	59,511,416
Treasury stock, shares (in shares)	4,395,817	4,145,481

Unaudited Condensed Consolida_3

Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Revenue	$ 19,416	$ 43,256
Costs and expenses:
Operating expenses (excluding depreciation and amortization)	22,841	43,968
Corporate general and administrative	4,493	7,281
Depreciation and amortization	2,191	2,260
Research and development	2,555	2,285
(Gain) loss on disposal of long-lived assets	(33)	1,097
Impairment of fixed and long-lived assets	57,454	0
Total costs and expenses	89,501	56,891
Loss from operations	(70,085)	(13,635)
Other (expense) income:
Interest expense	(4)	(1,998)
Other (expense) income, net	(47)	110
Total other expense	(51)	(1,888)
Loss before income taxes	(70,136)	(15,523)
Income tax benefit	6,169	311
Loss from continuing operations	(63,967)	(15,212)
Income from discontinued operations, net of tax	0	46,074
Net (loss) income	(63,967)	30,862
Amounts attributable to Flotek shareholders:
Loss from continuing operations	(63,967)	(15,212)
Income from discontinued operations, net of tax	0	46,074
Net (loss) income attributable to Flotek	$ (63,967)	$ 30,862
Basic earnings (loss) per common share:
Continuing operations (in dollars per share)	$ (1.07)	$ (0.26)
Discontinued operations, net of tax (in dollars per share)	0	0.79
Basic earnings (loss) per common share (in dollars per share)	(1.07)	0.53
Diluted earnings (loss) per common share:
Continuing operations (in dollars per share)	(1.07)	(0.26)
Discontinued operations, net of tax (in dollars per share)	0	0.79
Diluted earnings (loss) per common share (in dollars per share)	$ (1.07)	$ 0.53
Weighted average common shares:
Weighted average common shares used in computing basic earnings (loss) per common share (in shares)	59,836	58,373
Weighted average common shares used in computing diluted earnings (loss) per common share (in shares)	59,836	58,373

Unaudited Condensed Consolida_4

Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Loss from continuing operations	$ (63,967)	$ (15,212)
Income from discontinued operations, net of tax	0	46,074
Net (loss) income	(63,967)	30,862
Other comprehensive (loss) income:
Foreign currency translation adjustment	(123)	94
Comprehensive (loss) income	$ (64,090)	$ 30,956

Unaudited Condensed Consolida_5

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended				6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) income attributable to Flotek Industries, Inc. (Flotek)	$ (63,967)			$ 30,862
Less: Income from discontinued operations, net of tax	0	$ (2,425)	$ (1,608)	46,074	$ 44,466	$ 44,583	$ 42,158
Loss from continuing operations	(63,967)			(15,212)
Adjustments to reconcile loss from continuing operations to net cash used in operating activities:
Depreciation and amortization	2,191			2,260
Amortization of deferred financing costs	0			1,428
Provision for doubtful accounts	597			366
Provision for excess and obsolete inventory	529			0
Impairment of right-of-use assets	7,434			0
Impairment of fixed assets	30,178			0
Impairment of intangible assets	19,842			0
Loss on disposal of long-lived assets	(33)			1,097
Non-cash lease expense	184			230
Stock compensation expense	462			456
Deferred income tax provision	(133)			17,860
Reduction in tax benefit related to share-based awards	0			24
Changes in current assets and liabilities:
Accounts receivable, net	1,675			(420)
Inventories, net	4,793			(7,661)
Income taxes receivable	(6,212)			(247)
Other current assets	6,926			(18,199)
Accounts payable	(7,666)			(1,306)
Accrued liabilities	(17,522)			(8,157)
Income taxes payable	226			2,428
Interest payable	0			(8)
Net cash used in operating activities	(20,496)			(25,061)
Cash flows from investing activities:
Capital expenditures	(42)			(461)
Proceeds from sale of business	0			169,722
Proceeds from sale of assets	34			132
Abandoned/(purchase) of patents and other intangible assets	49			(103)
Net cash (used in) provided by investing activities	41			169,290
Cash flows from financing activities:
Borrowings on revolving credit facility	0			42,984
Repayments on revolving credit facility	0			(92,715)
Purchase of treasury stock related to share-based awards	(45)			(131)
Proceeds from sale of common stock	349			0
Payments for finance leases	(51)			0
Net cash provided by (used in) financing activities	253			(49,862)
Discontinued operations:
Net cash used in operating activities	0			(337)
Net cash provided by investing activities	0			337
Net cash flows provided by discontinued operations	0			0
Effect of changes in exchange rates on cash and cash equivalents	(109)			2
Net (decrease) increase in cash and cash equivalents and restricted cash	(20,311)			94,369
Cash and cash equivalents at the beginning of period	100,575		96,753	3,044	3,044	3,044	3,044
Restricted cash at the beginning of period	663		660	0	0	0	0
Cash and cash equivalents and restricted cash at beginning of period	101,238		$ 97,413	3,044	$ 3,044	$ 3,044	3,044
Cash and cash equivalents at end of period	80,263	100,575		96,753			100,575
Restricted cash at the end of period	664	663		660			663
Cash and cash equivalents and restricted cash at the end of period	$ 80,927	$ 101,238		$ 97,413			$ 101,238

Unaudited Condensed Consolida_6

Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Dec. 31, 2018		62,163,000	3,770,000
Beginning balance at Dec. 31, 2018	$ 202,013	$ 6	$ (33,237)	$ 343,536	$ (1,116)	$ (107,176)
Increase (Decrease) in Equity [Roll Forward]
Net (loss) income	30,862					30,862
Foreign currency translation adjustment	94				94
Restricted stock granted (in shares)		36,000
Restricted stock forfeited (in shares)			34,000
Treasury stock purchased (in shares)			41,000
Treasury stock purchased	(131)		$ (131)
Stock compensation expense	468			468
Ending balance (in shares) at Mar. 31, 2019		62,199,000	3,845,000
Ending balance at Mar. 31, 2019	233,306	$ 6	$ (33,368)	344,004	(1,022)	(76,314)
Beginning balance (in shares) at Dec. 31, 2018		62,163,000	3,770,000
Beginning balance at Dec. 31, 2018	202,013	$ 6	$ (33,237)	343,536	(1,116)	(107,176)
Increase (Decrease) in Equity [Roll Forward]
Net (loss) income	(33,915)
Ending balance (in shares) at Dec. 31, 2019		63,657,000	4,145,000
Ending balance at Dec. 31, 2019	172,029	$ 6	$ (33,484)	347,564	(966)	(141,091)
Increase (Decrease) in Equity [Roll Forward]
Net (loss) income	(63,967)					(63,967)
Foreign currency translation adjustment	(123)				(123)
Stock issued under employee stock purchase plan (in shares)			(13,000)
Stock issued under employee stock purchase plan	$ 11			11
Restricted stock granted (in shares)	681,190	681,000
Restricted stock granted	$ 338			338
Restricted stock forfeited (in shares)			241,000
Treasury stock purchased (in shares)			22,000
Treasury stock purchased	(45)		$ (45)
Stock compensation expense	462			462
Ending balance (in shares) at Mar. 31, 2020		64,338,000	4,395,000
Ending balance at Mar. 31, 2020	$ 108,705	$ 6	$ (33,529)	$ 348,375	$ (1,089)	$ (205,058)

Organization and Significant Ac

Organization and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and significant accounting policies	Organization and Significant Accounting Policies Organization and Nature of Operations Flotek Industries, Inc. (“Flotek” or the “Company”) is a global, diversified, technology-driven company that develops and supplies chemistry and services to the oil and gas industry. The Company’s Energy Chemistry Technology business designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. In the segment reported as discontinued operations at December 31, 2018, the Company processed citrus oil to produce (1) high value compounds used as additives by companies in the flavors and fragrances markets and (2) environmentally friendly chemistries for use in numerous industries around the world, including the oil and gas industry. Flotek operates in over seven domestic and international markets. Customers include major integrated oil and gas companies, oilfield services companies, independent oil and gas companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. Flotek was initially incorporated under the laws of the Province of British Columbia on May 17, 1985. On October 23, 2001, Flotek changed its corporate domicile to the state of Delaware. Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and accompanying footnotes (collectively the “Financial Statements”) reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (“Annual Report”). All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates. Potential Impact of COVID-19 On March 11, 2020, the World Health Organization declared the outbreak of the novel coronavirus (“COVID-19”) a global pandemic, which continues to spread throughout the United States and around the world. This outbreak has severely impacted global economic activity, and many countries and many states in the United States have reacted to the outbreak by instituting quarantines, mandating business and school closures and restricting travel. In addition, global oil producers, including the Organization of Petroleum Exporting Countries and other oil producing nations (“OPEC”), have experienced disagreements relating to oil production which has led to downward pressure on commodity prices. The effects of the COVID-19 pandemic, including actions taken by businesses and governments, have resulted in a significant and swift reduction in international and U.S. economic activity. These effects and the volatility in oil prices have materially and adversely affected, and may continue to materially and adversely affect, the demand for oil and natural gas, as well as for the Company’s services and products. The decline in the Company’s customers’ demand for the Company’s services and products is likely to have a material adverse impact on the Company’s financial condition, results of operations and cash flows in fiscal year 2020 and beyond. The Company anticipates a significant decrease in revenue and, as a result, has recorded an impairment to property, plant and equipment, intangible assets, and operating right-of-use assets. In addition, the Company adopted social distancing and work-from-home procedures, which have had and may continue to have an impact on the ability of employees and management of the Company to communicate and work efficiently. In response to COVID-19 and volatile energy market conditions, the Company has taken numerous actions to improve its financial flexibility which include, but are not limited to the following: • Reduced Chief Executive Officer’s salary by 20% and other executive officers by 10% in exchange for restricted stock, • Reduced Board of Directors compensation by 20% , • Reduced workforce by 35% , • Finalized plan to consolidate office space to occur in the second quarter 2020, relocating the Houston corporate headquarters personnel to the Company’s Houston Global Resource and Innovation facility, and • Decreased discretionary spending across all business operations. While the full impact of the COVID-19 outbreak is not yet known, we are closely monitoring the effects of the pandemic on commodity demands and on our customers, as well as on our operations and employees. These effects may include further adverse revenue and net income effects; disruptions to our operations; customer shutdowns of oil and gas exploration and production; employee impacts from illness, school closures and other community response measures; and temporary closures of our facilities or the facilities of our customers and suppliers. Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact net loss .

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recent accounting pronouncements	Recent Accounting Pronouncements Application of New Accounting Standards Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “ Leases .” This standard (ASC 842) requires the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 4 — “Leases” for further information surrounding adoption of this new standard. Effective January 1, 2019, the Company adopted ASU No. 2018-02, “ Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income .” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. Effective January 1, 2019, the Company adopted ASU No. 2018-07, “ Improvements to Nonemployee Share-Based Payment Accounting .” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Requirements and Disclosures Effective January 1, 2020, the Company adopted ASU No. 2018-13, “ Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement .” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Standards to be Adopted The Financial Accounting Standards Board (“FASB”) issued ASU No. 2019-12, “ Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes .” This standard removes specific exceptions to the general principles in Topic 740. The pronouncement is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted for public companies for periods in which financial statements have not yet been issued. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures. The FASB issued ASU No. 2016-13, “ Measurement of Credit Losses on Financial Instruments .” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures.

Discontinued Operations

Discontinued Operations	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations	Discontinued Operations During the fourth quarter of 2018, the Company initiated and began executing a strategic plan to sell its Consumer and Industrial Chemistry Technologies (“CICT”) segment. An investment banking advisory services firm was engaged and actively marketed this segment. The Company met all of the criteria to classify the CICT segment’s assets and liabilities as held for sale in the fourth quarter 2018. The Company has classified the assets, liabilities, and results of operations for this segment as “Discontinued Operations” for all periods presented. Disposal of the CICT reporting segment represented a strategic shift that may have a major effect on the Company’s operations and financial results. On January 10, 2019 , the Company entered into a Share Purchase Agreement with Archer-Daniels-Midland Company (“ADM”) for the sale of all of the shares representing membership interests in its wholly owned subsidiary, Florida Chemical Company, LLC (“FCC”), which represented the CICT segment. Effective February 28, 2019 , the Company completed the sale of the CICT segment to ADM for $175.0 million in cash consideration, with $4.4 million temporarily held in escrow by ADM for post-closing working capital adjustments for up to 90 days and $13.1 million temporarily held in escrow to satisfy potential indemnification claims by ADM with anticipated releases at 6 months , 12 months , and 15 months . Pursuant to the terms of the Share Purchase Agreement, Flotek Chemistry, LLC (“Flotek Chemistry”), a wholly owned subsidiary of the Company, entered into a supply agreement with FCC who will supply terpene at specified prices for specified quantities. The agreement will expire on December 31, 2023. As of December 31, 2019, the Company concluded that the original long-term supply agreement met the definition of a loss contract. As such, the Company recognized a loss as of December 31, 2019, capped by the price paid for the terpene supply agreement amendment, executed in February 2020, which aligned purchase commitments to expected usage for blended products as of December 31, 2019. Pursuant to the post-closing working capital dispute resolution procedures set forth in the Share Purchase Agreement, the Company and ADM engaged a neutral third party auditor to help reach agreement on the final post-closing working capital adjustment. In February 2020, the third party auditor ruled in favor of awarding ADM the entire disputed amount. As a result, the working capital adjustment escrow balance was released to ADM and a corresponding reduction was made to the gain on sale of business as of December 31, 2019. On February 26, 2020 , Flotek Chemistry, entered into an amendment to the terpene supply agreement between Flotek Chemistry and FCC. Pursuant to the terms and conditions of the amendment, the terpene supply agreement is amended to, among other things, (a) reduce the minimum quantity of terpene that Flotek Chemistry is required to purchase by approximately 3/4ths in 2020 and by approximately half in each of 2021, 2022 and 2023, (b) provide a fixed per pound price for terpene in 2020, (c) reduce the maximum amount of terpene subject to the terpene supply agreement by approximately 1/3rd, and (d) change the payment terms to net 45 days . In order to make the terms and conditions of the amendment to the terpene supply agreement effective, Flotek Chemistry made a one-time payment in February 2020 of $15.8 million to ADM. The expense associated with the terpene supply agreement amendment payment was recorded as a loss on contract purchase commitments, reported in operating expenses in continuing operations in December 2019. As of March 31, 2020 , the Company recognized an additional loss of $0.8 million associated with the amended terpene supply agreement due to adjustments in the Company’s expected usage of terpene in blended products in 2020. During the first quarter 2020, as scheduled, $3.3 million of the indemnity escrow was released to the Company. The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three months ended March 31, 2020 and 2019 (in thousands): Three months ended March 31, 2020 2019 Consumer and Industrial Chemistry Technologies Revenue $ — $ 11,031 Operating expenses — (11,447 ) Depreciation and amortization — — Research and development — (69 ) (Loss) income from operations — (485 ) Other income — 35 Gain on sale of business — 66,791 Income before income taxes — 66,341 Income tax expense — (20,267 ) Net income from discontinued operations $ — $ 46,074

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Leases Effective January 1, 2019, the Company adopted ASC 842 using the prospective method applied to those leases which were not completed as of December 31, 2018. The Company has leases for corporate offices, research and development facilities, warehouses, sales offices and equipment. The leases have remaining lease terms of 1 year to 10 years , some of which include options to extend the leases for up to 10 years . Upon adoption, the Company recorded operating lease right of use (“ROU”) assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. Leases with an initial expected term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the expected lease term. During the first quarter 2020, the Company made the decision to cease use of the corporate headquarter leased offices and move corporate employees to the Houston Global Research and Innovation Center (“GRIC”) during second quarter of 2020. In addition, the lease term liability for the corporate headquarters and GRIC locations and corresponding ROU assets were remeasured to remove extensions that would no longer be utilized and it was determined the Company was no longer reasonably certain to utilize the extension at the GRIC location . The remeasurement resulted in adjustments to lease liabilities and ROU assets totaling of $6.2 million each as of March 31, 2020. In addition, during the three months ended March 31, 2020, the Company recorded an impairment of the ROU assets totaling $7.4 million . See Note 9 - Impairment of Fixed and Long-lived Assets for further discussion of the impairment charge booked in the first quarter 2020. The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2020 2019 Operating lease expense $ 570 $ 653 Short-term lease expense 32 43 Interest on lease liabilities 4 — Total lease expense $ 606 $ 696 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 582 Operating cash flows from finance leases 3 — Financing cash flows from finance leases (51 ) — Maturities of lease liabilities are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2020 (excluding the three months ended March 31, 2020) $ 1,393 $ 54 2021 1,957 71 2022 1,912 47 2023 1,488 38 2024 1,338 23 Thereafter 8,153 — Total lease payments $ 16,241 $ 233 Less: Interest (5,320 ) (33 ) Present value of lease liabilities $ 10,921 $ 200 Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2020 December 31, 2019 Operating Leases Operating lease right-of-use assets $ 2,473 $ 16,388 Current portion of operating lease liabilities $ 1,167 $ 486 Long-term operating lease liabilities 9,754 16,973 Total operating lease liabilities $ 10,921 $ 17,459 Finance Leases Property and equipment $ 293 $ 293 Accumulated depreciation (38 ) (28 ) Property and equipment, net $ 255 $ 265 Current portion of finance lease liabilities $ 56 $ 55 Long-term finance lease liabilities 144 158 Total finance lease liabilities $ 200 $ 213 Weighted Average Remaining Lease Term Operating leases 9.2 years 16.6 years Finance leases 4.3 years 4.6 years Weighted Average Discount Rate Operating leases 8.9 % 8.9 % Finance leases 8.5 % 9.0 %
Leases	Leases Effective January 1, 2019, the Company adopted ASC 842 using the prospective method applied to those leases which were not completed as of December 31, 2018. The Company has leases for corporate offices, research and development facilities, warehouses, sales offices and equipment. The leases have remaining lease terms of 1 year to 10 years , some of which include options to extend the leases for up to 10 years . Upon adoption, the Company recorded operating lease right of use (“ROU”) assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. Leases with an initial expected term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the expected lease term. During the first quarter 2020, the Company made the decision to cease use of the corporate headquarter leased offices and move corporate employees to the Houston Global Research and Innovation Center (“GRIC”) during second quarter of 2020. In addition, the lease term liability for the corporate headquarters and GRIC locations and corresponding ROU assets were remeasured to remove extensions that would no longer be utilized and it was determined the Company was no longer reasonably certain to utilize the extension at the GRIC location . The remeasurement resulted in adjustments to lease liabilities and ROU assets totaling of $6.2 million each as of March 31, 2020. In addition, during the three months ended March 31, 2020, the Company recorded an impairment of the ROU assets totaling $7.4 million . See Note 9 - Impairment of Fixed and Long-lived Assets for further discussion of the impairment charge booked in the first quarter 2020. The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2020 2019 Operating lease expense $ 570 $ 653 Short-term lease expense 32 43 Interest on lease liabilities 4 — Total lease expense $ 606 $ 696 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 582 Operating cash flows from finance leases 3 — Financing cash flows from finance leases (51 ) — Maturities of lease liabilities are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2020 (excluding the three months ended March 31, 2020) $ 1,393 $ 54 2021 1,957 71 2022 1,912 47 2023 1,488 38 2024 1,338 23 Thereafter 8,153 — Total lease payments $ 16,241 $ 233 Less: Interest (5,320 ) (33 ) Present value of lease liabilities $ 10,921 $ 200 Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2020 December 31, 2019 Operating Leases Operating lease right-of-use assets $ 2,473 $ 16,388 Current portion of operating lease liabilities $ 1,167 $ 486 Long-term operating lease liabilities 9,754 16,973 Total operating lease liabilities $ 10,921 $ 17,459 Finance Leases Property and equipment $ 293 $ 293 Accumulated depreciation (38 ) (28 ) Property and equipment, net $ 255 $ 265 Current portion of finance lease liabilities $ 56 $ 55 Long-term finance lease liabilities 144 158 Total finance lease liabilities $ 200 $ 213 Weighted Average Remaining Lease Term Operating leases 9.2 years 16.6 years Finance leases 4.3 years 4.6 years Weighted Average Discount Rate Operating leases 8.9 % 8.9 % Finance leases 8.5 % 9.0 %

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	Revenue from Contracts with Customers Revenues are recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In recognizing revenue for products and services, the Company determines the transaction price of purchase orders or contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require significant judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services are distinct within the context of the contract. Variable consideration typically consists of product returns and is estimated based on the amount of consideration the Company expects to receive. Revenue accruals are recorded on an ongoing basis to reflect updated variable consideration information. The vast majority of the Company’s products are sold at a point in time and service contracts are short-term in nature. Sales are billed on a monthly basis with payment terms customarily 30-45 days for domestic and 60 day for international from invoice receipt. In addition, sales taxes are excluded from revenues. Disaggregation of Revenue The Company has disaggregated revenues by product sales (point-in-time revenue recognition) and service revenue (over-time revenue recognition), where product sales accounted for over 95% of total revenue for the three months ended March 31, 2020 and 2019 . The Company differentiates revenue and operating expenses (excluding depreciation and amortization) based on whether the source of revenue is attributable to products or services. Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands): Three months ended March 31, 2020 2019 Revenue: Products $ 18,800 $ 42,072 Services 616 1,184 $ 19,416 $ 43,256 Operating expenses (excluding depreciation and amortization): Products $ 22,534 $ 43,447 Services 307 521 $ 22,841 $ 43,968 Arrangements with Multiple Performance Obligations The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the total transaction price is allocated to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Standalone selling prices are generally determined based on the prices charged to customers (“observable standalone price”) or an expected cost plus a margin approach. For combined products and services within a contract, the Company accounts for individual products and services separately if they are distinct (i.e. if a product or service is separately identifiable from other items in the contract and if a customer can benefit from it on its own or with other resources that are readily available to the customer). The consideration is allocated between separate products and services within a contract based on the prices at the observable standalone price. For items that are not sold separately, the expected cost plus a margin approach is used to estimate the standalone selling price of each performance obligation. Contract Balances Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Accordingly, no revenue contracts give rise to contract assets or liabilities under ASC 606.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2020
Supplemental Cash Flow Elements [Abstract]
Supplemental cash flow information	Supplemental Cash Flow Information Supplemental cash flow information is as follows (in thousands): Three months ended March 31, 2020 2019 Supplemental cash payment information: Interest paid $ 4 $ 578 Income taxes paid, net of refunds (32 ) 22

Inventories

Inventories	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are as follows (in thousands): March 31, 2020 December 31, 2019 Raw materials $ 3,983 $ 4,339 Finished goods 17,287 24,569 Inventories 21,270 28,908 Less reserve for excess and obsolete inventory (4,948 ) (5,698 ) Inventories, net $ 16,322 $ 23,210

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Property and equipment	Property and Equipment Property and equipment are as follows (in thousands): March 31, 2020 December 31, 2019 Land $ 3,261 $ 4,440 Buildings and leasehold improvements 6,045 38,741 Machinery and equipment 6,848 27,694 Fixed assets in progress 21 — Furniture and fixtures 1,359 1,671 Transportation equipment 1,292 1,440 Computer equipment and software 1,464 3,348 Property and equipment 20,290 77,334 Less accumulated depreciation (12,344 ) (37,505 ) Property and equipment, net $ 7,946 $ 39,829 Depreciation expense totaled $1.7 million and $1.8 million for the three months ended March 31, 2020 and 2019 , respectively. During the three months ended March 31, 2020 an impairment was recognized for $30.2 million . No impairment was recognized for the three months December 31, 2019. Refer to Note 9 - Impairment of Fixed and Long-lived Assets within this Quarterly Report.

Impairment of Fixed and Long-li

Impairment of Fixed and Long-lived Assets	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Impairment of fixed and long-lived assets	Impairment of Fixed and Long-lived Assets During the first quarter 2020, the price of crude oil declined by over 50%, trading below $25 per barrel, causing a significant disruption across the industry, which began to negatively impact the Company’s results of operations. These declines of results of operations were driven by an oversupply of oil, insufficient storage, and demand destruction resulting from the reaction to COVID-19. Based on these factors, the Company concluded that a triggering event occurred and, accordingly, an interim quantitative impairment test was performed as of March 31, 2020. As of March 31, 2020, the Company had one single reporting unit, ECT (“Asset Group”), which has historically been identified for purposes of long-lived asset impairment assessments. The Company identified the patents and technology as the primary asset within the Asset Group. Management considered the existing formulation/intellectual property portfolio to be the primary cash generating long-lived asset being amortized, given the specialty nature of their use and applications for the oil and gas industry. The formulations are designed to maximize recovery in both new and mature fields. Management believes the formulations are the primary reason for maintaining existing customer relationships, as well as establishing new customers. The first step in the impairment test is to determine whether the Asset Group is recoverable. Using the income approach, the fair value of the Asset Group was determined based on the present value of future cash flows. The Company utilized internal forecast trends and potential growth rates to estimate future cash flows of the Asset Group. Based on the results of the quantitative assessment, the Company concluded the carrying value of the Asset Group exceeded its fair value as of March 31, 2020 and an impairment loss of $57.5 million was recorded as a result of the adverse effect of the COVID-19 pandemic and the related impact on oil and natural gas prices on projections of future cash flows. The Company recorded impairment charges during the three months ended March 31, 2020 as follows (in thousands): Property and equipment, net $ 30,178 Operating lease right-of-use assets 7,434 Other Intangibles: Patents 9,902 Customer Lists 9,165 Intangibles assets in progress 596 Trademarks and brand names 179 Total Other Intangibles 19,842 Total Long-lived Assets $ 57,454

Other Intangible Assets

Other Intangible Assets	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Other intangible assets	Other Intangible Assets Other intangible assets are as follows (in thousands): March 31, 2020 December 31, 2019 Cost (1) Accumulated Amortization Cost Accumulated Amortization Finite-lived intangible assets: Patents and technology $ — $ — $ 17,493 $ 6,715 Customer lists — — 15,367 6,013 Trademarks and brand names — — 1,351 1,160 Intangible assets in progress — — — — Total finite-lived intangible assets $ — — $ 34,211 13,888 Carrying value: Other intangible assets, net $ — $ 20,323 (1) During the three months ended March 31, 2020, after $0.5 million of amortization expense was recorded, the Company recorded impairment charges to patents of $9.9 million , customer lists of $9.2 million , intangibles in progress of $0.6 million and trademarks and brand names of $0.2 million . See Note 9 - Impairment of Fixed and Long-lived Assets. Amortization of finite-lived intangible assets acquired totaled $0.5 million and $0.5 million for the three months ended March 31, 2020 and 2019 , respectively.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings (loss) per share	Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three months ended March 31, 2020 and 2019 , since including them would have an anti-dilutive effect on loss per share due to the net loss incurred during the periods. Securities convertible into shares of common stock that were not considered in the diluted loss per share calculations were 0.4 million restricted stock units and 3.0 million stock options for the three months ended March 31, 2020 and 0.2 million restricted stock units for the three months ended March 31, 2019

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair value measurements	Fair Value Measurements Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs. Fair Value of Other Financial Instruments The carrying amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate fair value due to the short-term nature of these accounts. The Company had total cash of $80.3 million , which consisted of cash equivalents of $25.1 million in a government money market account and cash deposits of $45.9 million in an interest bearing demand deposit account and $9.3 million in operating cash accounts, at March 31, 2020 , and $100.6 million , which consisted of cash equivalents of $48.4 million in a government money market account and cash deposits of $45.7 million in an interest bearing demand deposit and $6.5 million in operating cash accounts, at December 31, 2019 . Liabilities Measured at Fair Value on a Recurring Basis At March 31, 2020 and December 31, 2019, no liabilities were required to be measured at fair value on a recurring basis. There were no transfers in or out of either Level 1, Level 2, or Level 3 fair measurements during the periods ending March 31, 2020 and December 31, 2019. Assets Measured at Fair Value on a Nonrecurring Basis The Company’s non-financial assets, including property and equipment, and other intangible assets are measured at fair value on a non-recurring basis and are subject to fair value adjustment in certain circumstances. During the three months ended March 31, 2020, the Company recorded an impairment of $57.5 million for impairment on long-lived assets. Management inputs used in fair value measurement were classified as Level 3.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows: Three months ended March 31, 2020 2019 U.S. federal statutory tax rate 21.0 % 21.0 % State income taxes, net of federal benefit (0.1 ) 0.5 Non-U.S. income taxed at different rates 0.1 1.3 Reduction in tax benefit related to stock-based awards (0.2 ) (2.3 ) Non-deductible expenses (0.1 ) (0.6 ) Research and development credit (expense) 0.1 0.8 Increase in valuation allowance (15.0 ) (18.5 ) Effect of tax rate differences of NOL carryback 3.0 — Other — (0.2 ) Effective income tax rate 8.8 % 2.0 % On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted in response to the COVID-19 pandemic. Among other things, the CARES Act provided the ability for taxpayers to carryback a net operating loss (“NOL”) arising in a taxable year beginning after December 31, 2017 and before January 1, 2021 to each of the five years preceding the year of the loss. Based on the Company’s analysis of the extended NOL carryback provision, it recorded a tax receivable of $6.1 million and filed Form 1139 for a tentative refund of the same amount in April 2020. The refund reflects $4.0 million related to the carrying back of 2018 NOLs to 2013 and $2.1 million in tax benefit relating to the difference in the current U.S. federal tax rate of 21% and the tax rate of 35% applicable in 2013. Fluctuations in effective tax rates have historically been impacted by permanent tax differences with no associated income tax impact, changes in the valuation allowance, changes in state apportionment factors, including the effect on state deferred tax assets and liabilities, and non-U.S. income taxed at different rates, except for the NOL carryback claim discussed above. Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted rates and laws that will be in effect when the differences are expected to reverse. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. In assessing the need for a valuation allowance, the Company considers all available objective and verifiable evidence, both positive and negative, including historical levels of pre-tax income (loss) both on a consolidated basis and tax reporting entity basis, legislative developments, and expectations and risks associated with estimates of future pre-tax income. As of December 31, 2019, the Company determined that it was more likely than not that it would not realize the benefits of certain deferred tax assets and, therefore, it recorded a $19.9 million valuation allowance against the carrying value of net deferred tax assets, except for deferred tax liabilities related to certain state jurisdictions. As a result of the NOL carryback allowed by the CARES Act, the Company released a valuation allowance of $4.0 million related to its deferred tax assets attributable to its U.S. federal NOLs. The Company continues to have a full valuation allowance against net deferred tax liabilities as it is not more-likely-than-not they will be utilized.

Common Stock

Common Stock	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Common Stock	Common Stock As of March 31, 2020, the Company’s Amended and Restated Certificate of Incorporation, as amended on November 9, 2009, authorized the Company to issue up to 80 million shares of common stock, par value $0.0001 per share, and 100,000 shares of one or more series of preferred stock, par value $0.0001 per share. On May 5, 2020, shareholders approved an increase in the number of authorized shares by 60.0 million to 140.0 million . A reconciliation of changes in common shares issued during the three months ended March 31, 2020 is as follows: Shares issued at December 31, 2019 63,656,897 Issued as restricted stock award grants 681,190 Shares issued at March 31, 2020 64,338,087 Stock Repurchase Program In June 2015, the Company’s Board of Directors authorized the repurchase of up to $50 million of the Company’s common stock. Repurchases may be made in the open market or through privately negotiated transactions. Through March 31, 2020 , the Company had repurchased $0.3 million of its common stock under this authorization in June 2015. During the three months ended March 31, 2020 and 2019 , the Company did no t repurchase any shares of its outstanding common stock under this authorization. At March 31, 2020 , the Company has $49.7 million remaining repurchase capacity under its share repurchase program.

Business Segment, Geographic an

Business Segment, Geographic and Major Customer Information	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Business Segment, Geographic and Major Customer Information	Business Segment, Geographic and Major Customer Information Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies. Energy Chemistry Technologies business designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities as well as management of loading facilities and blending operations for oilfield services companies. The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment. Summarized financial information of the reportable segments is as follows (in thousands): For the three months ended March 31, Energy Chemistry Technologies Corporate and Other Total 2020 Net revenue from external customers $ 19,416 $ — $ 19,416 Loss from operations, including impairment (70,269 ) 184 (70,085 ) Depreciation and amortization 1,809 382 2,191 Capital expenditures 42 — 42 2019 Net revenue from external customers $ 43,256 $ — $ 43,256 Loss from operations (4,703 ) (8,932 ) (13,635 ) Depreciation and amortization 1,785 475 2,260 Capital expenditures 461 — 461 Assets of the Company by reportable segments are as follows (in thousands): March 31, 2020 December 31, 2019 Energy Chemistry Technologies $ 45,883 $ 116,110 Corporate and Other 90,891 114,490 Total assets 136,774 230,600 Geographic Information Revenue by country is based on the location where services are provided and products are used. No individual country other than the United States (“U.S.”) accounted for more than 10% of revenue. Revenue by geographic location is as follows (in thousands): Three months ended March 31, 2020 2019 U.S. $ 15,775 $ 38,875 Other countries 3,641 4,381 Total $ 19,416 $ 43,256 Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements. Major Customers Revenue from major customers, as a percentage of consolidated revenue, is as follows: Three months ended March 31, 2020 2019 Customer A 39.9 % * Customer B 17.9 % 19.0 % Customer C * 12.6 % * This customer did not account for more than 10% of revenue.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and Contingencies Class Action Litigation On March 30, 2017, the U.S. District Court for the Southern District of Texas granted the Company’s motion to dismiss the four consolidated putative securities class action lawsuits that were filed in November 2015, against the Company and certain of its officers. The lawsuits were previously consolidated into a single case, and a consolidated amended complaint had been filed. The consolidated amended complaint asserted that the Company made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. The complaint sought an award of damages in an unspecified amount on behalf of a putative class consisting of persons who purchased the Company’s common stock between October 23, 2014 and November 9, 2015, inclusive. The lead plaintiff appealed the District Court’s decision granting the motion to dismiss. On February 7, 2019, a three-judge panel of the United States Court of Appeals for the Fifth Circuit issued a unanimous opinion affirming the District Court’s judgment of dismissal in its entirety. Other Litigation The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity. Concentrations and Credit Risk The majority of the Company’s revenue is derived from the oil and gas industry. Customers include major oilfield services companies, major integrated oil and natural gas companies, independent oil and natural gas companies, pressure pumping service companies, and state-owned national oil companies. This concentration of customers in one industry increases credit and business risks. The Company is subject to concentrations of credit risk within trade accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in accounts in two major financial institutions and balances often exceed insurable amounts.

Related Party Transaction

Related Party Transaction	3 Months Ended
	Mar. 31, 2020
Related Party Transactions [Abstract]
Related party transaction	Related Party Transaction In January 2017, the Internal Revenue Service (“IRS”) notified the Company that it was examining the Company’s federal tax returns for the year ended December 31, 2014. As a result of this examination, the IRS informed the Company on May 1, 2019 that certain employment taxes related to the compensation of our former CEO, Mr. Chisholm, were not properly withheld in 2014 and proposed an adjustment. Mr. Chisholm’s affiliated companies through which he provided his services have agreed to indemnify the Company for any such taxes, and Mr. Chisholm has executed a personal guaranty in favor of the Company, supporting this indemnification. At June 30, 2019, the Company recorded a liability of $2.4 million related to the estimated employment tax under-withholding for the years 2014 through 2018. By September 30, 2019, the liability totaled $1.8 million , after the Company paid $0.6 million to the IRS for these taxes and made an additional accrual covering the estimated under-withholding tax liability through 2019. In addition, at September 30, 2019 the Company recorded a receivable from the affiliated companies totaling $2.4 million . In October 2019, an amendment to the employment agreement was executed, giving the Company the contractual right of offset for any amounts owed to the Company against, and giving the Company the right to withhold payments equal to amounts reasonably estimated to potentially become due to the Company by the affiliated companies from any amounts owed under the employment agreement. During the three months ended March 31, 2020, an additional accrual was recorded for $0.2 million related to potential penalties and interest on the IRS obligation. As of March 31, 2020, the receivable from Mr. Chisholm was $2.3 million , which is equal to the payable to the IRS and was netted with Mr. Chisholm’s severance liability. Both the IRS and severance liabilities are recorded in accrued liabilities on the consolidated balance sheet.

Revision of Prior Financial Sta

Revision of Prior Financial Statements	3 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Revision of Prior Financial Statements	Revision of Prior Financial Statements During the review of the Consolidated Balance Sheet during the three months ended March 31, 2020, management noted two separate errors that impact prior periods as follows: • Trademarks and brand names with a carrying value of $2.8 million that were transferred in the sale of Florida Chemical to ADM on February 28, 2019 were not removed from the Consolidated Balance Sheet at the time of the sale. • Gross profit in intercompany inventory was not properly relieved and recorded as a reduction in cost of sales when the related inventory was sold to third parties. The revisions discussed above impacted the financial statements as follows (in thousands): As of March 31, 2019 As previously reported Revisions As revised Inventories, net $ 34,358 $ 1,019 $ 35,377 Other intangible assets, net 24,978 (2,760 ) 22,218 Total Assets 282,792 (1,741 ) 281,051 Total Liabilities and Stockholders' Equity 282,792 (1,741 ) 281,051 For the three months ended March 31, 2019 As previously reported Revisions As revised Operating expenses $ 44,599 $ (631 ) $ 43,968 Income tax benefit 774 (463 ) 311 Loss from continuing operations (15,380 ) 168 (15,212 ) Income from discontinued operations, net of tax 48,372 (2,298 ) 46,074 Net income 32,992 (2,130 ) 30,862 As of June 30, 2019 As previously reported Revisions As revised Inventories, net $ 26,442 $ 1,204 $ 27,646 Other intangible assets, net 24,290 (2,760 ) 21,530 Total Assets 263,816 (1,556 ) 262,260 Total Liabilities and Stockholders' Equity 263,816 (1,556 ) 262,260 For the three months ended June 30, 2019 For the six months ended June 30, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 38,306 $ (185 ) $ 38,121 $ 82,905 $ (816 ) $ 82,089 Income tax benefit 192 — 192 966 (463 ) 503 Loss from continuing operations (12,990 ) 185 (12,805 ) (28,370 ) 353 (28,017 ) (Loss) income from discontinued operations, net of tax (1,608 ) — (1,608 ) 46,764 (2,298 ) 44,466 Net (loss) income (14,598 ) 185 (14,413 ) 18,394 (1,945 ) 16,449 As of September 30, 2019 As previously reported Revisions As revised Inventories, net $ 24,333 $ 1,271 $ 25,604 Other intangible assets, net 23,578 (2,760 ) 20,818 Total Assets 249,357 (1,489 ) 247,868 Total Liabilities and Stockholders' Equity 249,357 (1,489 ) 247,868 For the three months ended September 30, 2019 For the nine months ended September 30, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 23,689 $ (67 ) $ 23,622 $ 106,594 $ (883 ) $ 105,711 Income tax benefit 191 — 191 1,157 (463 ) 694 Loss from continuing operations (11,227 ) 67 (11,160 ) (39,597 ) 420 (39,177 ) Income from discontinued operations, net of tax 117 — 117 46,881 (2,298 ) 44,583 Net (loss) income (11,110 ) 67 (11,043 ) 7,284 (1,878 ) 5,406 As of December 31, 2019 As previously reported Revisions As revised Inventories, net $ 21,697 $ 1,513 $ 23,210 Other intangible assets, net 23,083 (2,760 ) 20,323 Total Assets 231,847 (1,247 ) 230,600 Total Liabilities and Stockholders' Equity 231,847 (1,247 ) 230,600 For the three months ended December 31, 2019 For the year ended December 31, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 42,631 $ (242 ) $ 42,389 $ 149,225 $ (1,125 ) $ 148,100 Income tax (expense) benefit (956 ) — (956 ) 201 (463 ) (262 ) Loss from continuing operations (37,138 ) 242 (36,896 ) (76,735 ) 662 (76,073 ) (Loss) income from discontinued operations, net of tax (2,425 ) — (2,425 ) 44,456 (2,298 ) 42,158 Net loss (39,563 ) 242 (39,321 ) (32,279 ) (1,636 ) (33,915 ) Management evaluated the impact on previously issued financial statements and concluded the impact was not material.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events In April 2020, the Company was notified by the New York Exchange (“NYSE”) that the average closing stock price had fallen below the minimum average closing price required to maintain listing on the NYSE. The Company initially had until October 2020 to regain compliance with the minimum share price requirement, but due to recent market turmoil, the NYSE has filed a rule change related to the compliance periods for price-based listing requirements through June 30, 2020, which extended the Company’s compliance period to December 2020. In April 2020, the Company filed a Form 1139 for a tentative tax refund of $6.1 million pursuant to the CARES Act that extended NOL carryback provisions and recorded an income tax receivable of the same amount at March 31, 2020. In April 2020, the Company received a $4.8 million loan under the Paycheck Protection Program (“PPP”) which was created through the Coronavirus Aid, Relief, and Economic Act (“CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The loan has a fixed interest rate of 1% , matures in two years and payments are deferred for six months. A portion of the loan is eligible for forgiveness by the SBA depending upon the extent of proceeds used for payroll costs and other designated expenses incurred for up to 24 weeks following loan origination, subject to adjustments for headcount reductions and compensation limits and provided that at least 60% of the eligible costs incurred are used for payroll. Receipt of these funds requires the Company to, in good faith, certify that the current economic uncertainty made the loan request necessary to support ongoing operations of the Company. This certification further requires the Company to take into account current business activity and the ability to access other sources of liquidity sufficient to support ongoing operations in a manner that is not significantly detrimental to the business. At the annual shareholders’ meeting held on May 5, 2020, the shareholders approved an increase in the number of authorized shares by 60.0 million to 140.0 million . The additional authorized shares of common stock will be available for corporate purposes, including acquisitions of other companies, products, technologies or businesses. On May 18, 2020, the Company announced the acquisition of 100% of the equity interests in JP3 Measurement, LLC (“JP3”), a privately held leading data and analytics technology company, in exchange for cash-and-stock valued at approximately $34.4 million and the assumption of $1.3 million of debt. JP3’s innovative, real-time data platforms combine the energy industry’s only field-deployable, inline optical analyzer with proprietary cloud visualization and analytics to radically increase processing efficiencies and valuation of natural gas, crude oil and refined fuels. The transaction positions Flotek for accelerated growth and diversifies the Company’s business across all segments of the hydrocarbon value chain, while enhancing existing chemistry applications and broadening its customer reach across the midstream and downstream sectors. In May 2020, the Company finalized a contract to terminate the lease of its Houston corporate headquarters office in exchange for a one-time payment of $1.0 million . On June 9, 2020, the board of directors of the Company rescinded the authorization to repurchase the Company’s stock that had been previously approved in June 2015.

Organization and Significant _2

Organization and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying Unaudited Condensed Consolidated Financial Statements and accompanying footnotes (collectively the “Financial Statements”) reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2019 (“Annual Report”).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates.
Reclassifications	Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact net loss .
Recent accounting pronouncements	Recent Accounting Pronouncements Application of New Accounting Standards Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “ Leases .” This standard (ASC 842) requires the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million , representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 4 — “Leases” for further information surrounding adoption of this new standard. Effective January 1, 2019, the Company adopted ASU No. 2018-02, “ Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income .” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. Effective January 1, 2019, the Company adopted ASU No. 2018-07, “ Improvements to Nonemployee Share-Based Payment Accounting .” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from non-employees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Requirements and Disclosures Effective January 1, 2020, the Company adopted ASU No. 2018-13, “ Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement .” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures. New Accounting Standards to be Adopted The Financial Accounting Standards Board (“FASB”) issued ASU No. 2019-12, “ Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes .” This standard removes specific exceptions to the general principles in Topic 740. The pronouncement is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years, with early adoption permitted for public companies for periods in which financial statements have not yet been issued. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures. The FASB issued ASU No. 2016-13, “ Measurement of Credit Losses on Financial Instruments .” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for smaller reporting companies for fiscal years beginning after December 15, 2022. The Company is currently evaluating the impact of this standard on the consolidated financial statements and related disclosures.
Earnings (loss) per share	Earnings (Loss) Per Share Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive. Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three months ended March 31, 2020 and 2019
Fair value measurements	Fair Value Measurements Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement. • Level 1 — Quoted prices in active markets for identical assets or liabilities; • Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and • Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.
Segment Information	Segment Information Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies. Energy Chemistry Technologies business designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities as well as management of loading facilities and blending operations for oilfield services companies. The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment.

Discontinued Operations (Tables

Discontinued Operations (Tables)	3 Months Ended
	Mar. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]
Summary of financial information has been segregated from continuing operations	The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three months ended March 31, 2020 and 2019 (in thousands): Three months ended March 31, 2020 2019 Consumer and Industrial Chemistry Technologies Revenue $ — $ 11,031 Operating expenses — (11,447 ) Depreciation and amortization — — Research and development — (69 ) (Loss) income from operations — (485 ) Other income — 35 Gain on sale of business — 66,791 Income before income taxes — 66,341 Income tax expense — (20,267 ) Net income from discontinued operations $ — $ 46,074

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Schedule of components of lease expense and supplemental cash flow information	The components of lease expense and supplemental cash flow information are as follows (in thousands): Three months ended March 31, 2020 2019 Operating lease expense $ 570 $ 653 Short-term lease expense 32 43 Interest on lease liabilities 4 — Total lease expense $ 606 $ 696 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows from operating leases $ 584 $ 582 Operating cash flows from finance leases 3 — Financing cash flows from finance leases (51 ) —
Schedule of maturities of lease liabilities	Maturities of lease liabilities are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2020 (excluding the three months ended March 31, 2020) $ 1,393 $ 54 2021 1,957 71 2022 1,912 47 2023 1,488 38 2024 1,338 23 Thereafter 8,153 — Total lease payments $ 16,241 $ 233 Less: Interest (5,320 ) (33 ) Present value of lease liabilities $ 10,921 $ 200
Schedule of maturities of lease liabilities	Maturities of lease liabilities are as follows (in thousands): Years ending December 31, Operating Leases Finance Leases 2020 (excluding the three months ended March 31, 2020) $ 1,393 $ 54 2021 1,957 71 2022 1,912 47 2023 1,488 38 2024 1,338 23 Thereafter 8,153 — Total lease payments $ 16,241 $ 233 Less: Interest (5,320 ) (33 ) Present value of lease liabilities $ 10,921 $ 200
Schedule of supplemental balance sheet information	Supplemental balance sheet information related to leases is as follows (in thousands): March 31, 2020 December 31, 2019 Operating Leases Operating lease right-of-use assets $ 2,473 $ 16,388 Current portion of operating lease liabilities $ 1,167 $ 486 Long-term operating lease liabilities 9,754 16,973 Total operating lease liabilities $ 10,921 $ 17,459 Finance Leases Property and equipment $ 293 $ 293 Accumulated depreciation (38 ) (28 ) Property and equipment, net $ 255 $ 265 Current portion of finance lease liabilities $ 56 $ 55 Long-term finance lease liabilities 144 158 Total finance lease liabilities $ 200 $ 213 Weighted Average Remaining Lease Term Operating leases 9.2 years 16.6 years Finance leases 4.3 years 4.6 years Weighted Average Discount Rate Operating leases 8.9 % 8.9 % Finance leases 8.5 % 9.0 %

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Schedule of disaggregation of revenue	Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands): Three months ended March 31, 2020 2019 Revenue: Products $ 18,800 $ 42,072 Services 616 1,184 $ 19,416 $ 43,256 Operating expenses (excluding depreciation and amortization): Products $ 22,534 $ 43,447 Services 307 521 $ 22,841 $ 43,968

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2020
Supplemental Cash Flow Elements [Abstract]
Components of supplemental cash flow information	Supplemental cash flow information is as follows (in thousands): Three months ended March 31, 2020 2019 Supplemental cash payment information: Interest paid $ 4 $ 578 Income taxes paid, net of refunds (32 ) 22

Inventories (Tables)

Inventories (Tables)	3 Months Ended
	Mar. 31, 2020
Inventory Disclosure [Abstract]
Schedule of components of inventory	Inventories are as follows (in thousands): March 31, 2020 December 31, 2019 Raw materials $ 3,983 $ 4,339 Finished goods 17,287 24,569 Inventories 21,270 28,908 Less reserve for excess and obsolete inventory (4,948 ) (5,698 ) Inventories, net $ 16,322 $ 23,210

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Components of property and equipment	Property and equipment are as follows (in thousands): March 31, 2020 December 31, 2019 Land $ 3,261 $ 4,440 Buildings and leasehold improvements 6,045 38,741 Machinery and equipment 6,848 27,694 Fixed assets in progress 21 — Furniture and fixtures 1,359 1,671 Transportation equipment 1,292 1,440 Computer equipment and software 1,464 3,348 Property and equipment 20,290 77,334 Less accumulated depreciation (12,344 ) (37,505 ) Property and equipment, net $ 7,946 $ 39,829

Impairment of Fixed and Long-_2

Impairment of Fixed and Long-lived Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Impairment Charges	The Company recorded impairment charges during the three months ended March 31, 2020 as follows (in thousands): Property and equipment, net $ 30,178 Operating lease right-of-use assets 7,434 Other Intangibles: Patents 9,902 Customer Lists 9,165 Intangibles assets in progress 596 Trademarks and brand names 179 Total Other Intangibles 19,842 Total Long-lived Assets $ 57,454

Other Intangible Assets (Tables

Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of other intangible assets	Other intangible assets are as follows (in thousands): March 31, 2020 December 31, 2019 Cost (1) Accumulated Amortization Cost Accumulated Amortization Finite-lived intangible assets: Patents and technology $ — $ — $ 17,493 $ 6,715 Customer lists — — 15,367 6,013 Trademarks and brand names — — 1,351 1,160 Intangible assets in progress — — — — Total finite-lived intangible assets $ — — $ 34,211 13,888 Carrying value: Other intangible assets, net $ — $ 20,323 (1) During the three months ended March 31, 2020, after $0.5 million of amortization expense was recorded, the Company recorded impairment charges to patents of $9.9 million , customer lists of $9.2 million , intangibles in progress of $0.6 million and trademarks and brand names of $0.2 million . See Note 9 - Impairment of Fixed and Long-lived Assets.

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Reconciliation of effective tax rate to the U.S. federal statutory tax rate	A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows: Three months ended March 31, 2020 2019 U.S. federal statutory tax rate 21.0 % 21.0 % State income taxes, net of federal benefit (0.1 ) 0.5 Non-U.S. income taxed at different rates 0.1 1.3 Reduction in tax benefit related to stock-based awards (0.2 ) (2.3 ) Non-deductible expenses (0.1 ) (0.6 ) Research and development credit (expense) 0.1 0.8 Increase in valuation allowance (15.0 ) (18.5 ) Effect of tax rate differences of NOL carryback 3.0 — Other — (0.2 ) Effective income tax rate 8.8 % 2.0 %

Common Stock (Tables)

Common Stock (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of reconciliation of changes in common shares issued	A reconciliation of changes in common shares issued during the three months ended March 31, 2020 is as follows: Shares issued at December 31, 2019 63,656,897 Issued as restricted stock award grants 681,190 Shares issued at March 31, 2020 64,338,087

Business Segment, Geographic _2

Business Segment, Geographic and Major Customer Information (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Summary of financial information regarding reportable segments	Summarized financial information of the reportable segments is as follows (in thousands): For the three months ended March 31, Energy Chemistry Technologies Corporate and Other Total 2020 Net revenue from external customers $ 19,416 $ — $ 19,416 Loss from operations, including impairment (70,269 ) 184 (70,085 ) Depreciation and amortization 1,809 382 2,191 Capital expenditures 42 — 42 2019 Net revenue from external customers $ 43,256 $ — $ 43,256 Loss from operations (4,703 ) (8,932 ) (13,635 ) Depreciation and amortization 1,785 475 2,260 Capital expenditures 461 — 461 Assets of the Company by reportable segments are as follows (in thousands): March 31, 2020 December 31, 2019 Energy Chemistry Technologies $ 45,883 $ 116,110 Corporate and Other 90,891 114,490 Total assets 136,774 230,600
Schedule of revenue by geographic location	Revenue by geographic location is as follows (in thousands): Three months ended March 31, 2020 2019 U.S. $ 15,775 $ 38,875 Other countries 3,641 4,381 Total $ 19,416 $ 43,256
Schedule of revenue by major customer	Revenue from major customers, as a percentage of consolidated revenue, is as follows: Three months ended March 31, 2020 2019 Customer A 39.9 % * Customer B 17.9 % 19.0 % Customer C * 12.6 % * This customer did not account for more than 10% of revenue.

Revision of Prior Financial S_2

Revision of Prior Financial Statements (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Schedule of impacted financial statements	The revisions discussed above impacted the financial statements as follows (in thousands): As of March 31, 2019 As previously reported Revisions As revised Inventories, net $ 34,358 $ 1,019 $ 35,377 Other intangible assets, net 24,978 (2,760 ) 22,218 Total Assets 282,792 (1,741 ) 281,051 Total Liabilities and Stockholders' Equity 282,792 (1,741 ) 281,051 For the three months ended March 31, 2019 As previously reported Revisions As revised Operating expenses $ 44,599 $ (631 ) $ 43,968 Income tax benefit 774 (463 ) 311 Loss from continuing operations (15,380 ) 168 (15,212 ) Income from discontinued operations, net of tax 48,372 (2,298 ) 46,074 Net income 32,992 (2,130 ) 30,862 As of June 30, 2019 As previously reported Revisions As revised Inventories, net $ 26,442 $ 1,204 $ 27,646 Other intangible assets, net 24,290 (2,760 ) 21,530 Total Assets 263,816 (1,556 ) 262,260 Total Liabilities and Stockholders' Equity 263,816 (1,556 ) 262,260 For the three months ended June 30, 2019 For the six months ended June 30, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 38,306 $ (185 ) $ 38,121 $ 82,905 $ (816 ) $ 82,089 Income tax benefit 192 — 192 966 (463 ) 503 Loss from continuing operations (12,990 ) 185 (12,805 ) (28,370 ) 353 (28,017 ) (Loss) income from discontinued operations, net of tax (1,608 ) — (1,608 ) 46,764 (2,298 ) 44,466 Net (loss) income (14,598 ) 185 (14,413 ) 18,394 (1,945 ) 16,449 As of September 30, 2019 As previously reported Revisions As revised Inventories, net $ 24,333 $ 1,271 $ 25,604 Other intangible assets, net 23,578 (2,760 ) 20,818 Total Assets 249,357 (1,489 ) 247,868 Total Liabilities and Stockholders' Equity 249,357 (1,489 ) 247,868 For the three months ended September 30, 2019 For the nine months ended September 30, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 23,689 $ (67 ) $ 23,622 $ 106,594 $ (883 ) $ 105,711 Income tax benefit 191 — 191 1,157 (463 ) 694 Loss from continuing operations (11,227 ) 67 (11,160 ) (39,597 ) 420 (39,177 ) Income from discontinued operations, net of tax 117 — 117 46,881 (2,298 ) 44,583 Net (loss) income (11,110 ) 67 (11,043 ) 7,284 (1,878 ) 5,406 As of December 31, 2019 As previously reported Revisions As revised Inventories, net $ 21,697 $ 1,513 $ 23,210 Other intangible assets, net 23,083 (2,760 ) 20,323 Total Assets 231,847 (1,247 ) 230,600 Total Liabilities and Stockholders' Equity 231,847 (1,247 ) 230,600 For the three months ended December 31, 2019 For the year ended December 31, 2019 As previously reported Revisions As revised As previously reported Revisions As revised Operating expenses $ 42,631 $ (242 ) $ 42,389 $ 149,225 $ (1,125 ) $ 148,100 Income tax (expense) benefit (956 ) — (956 ) 201 (463 ) (262 ) Loss from continuing operations (37,138 ) 242 (36,896 ) (76,735 ) 662 (76,073 ) (Loss) income from discontinued operations, net of tax (2,425 ) — (2,425 ) 44,456 (2,298 ) 42,158 Net loss (39,563 ) 242 (39,321 ) (32,279 ) (1,636 ) (33,915 ) Management evaluated the impact on previously issued financial statements and concluded the impact was not material.

Organization and Significant _3

Organization and Significant Accounting Policies (Details)	3 Months Ended
	Mar. 31, 2020country
Unusual or Infrequent Item, or Both [Line Items]
Number of countries Flotek actively markets products and services (over)	7
COVID-19 pandemic
Unusual or Infrequent Item, or Both [Line Items]
Reduction in workforce (in percentage)	35.00%
Chief Executive Officer | COVID-19 pandemic
Unusual or Infrequent Item, or Both [Line Items]
Decrease in salaries (in percentage)	20.00%
Executive Officers | COVID-19 pandemic
Unusual or Infrequent Item, or Both [Line Items]
Decrease in salaries (in percentage)	10.00%
Board of Directors | COVID-19 pandemic
Unusual or Infrequent Item, or Both [Line Items]
Decrease in salaries (in percentage)	20.00%

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets	$ 2,473	$ 16,388
Long-term operating lease liabilities	9,754	$ 16,973
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets	6,200		$ 18,400
Long-term operating lease liabilities	$ 3,400		$ 18,400

Discontinued Operations - Addit

Discontinued Operations - Additional Disclosures (Details) - USD ($) $ in Millions	Feb. 26, 2020	Feb. 28, 2019	Mar. 31, 2020
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Payment for amendment agreement	$ 15.8
Escrow deposit			$ 3.3
Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration		$ 175
Working Adjustment Period 1 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent liabilities remaining period		90 days
Contingent liabilities remaining		$ 4.4
Working Adjustment Period 2-4 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent liabilities remaining		$ 13.1
Working Adjustment Period 2 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent liabilities remaining period		6 months
Working Adjustment Period 3 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent liabilities remaining period		12 months
Working Adjustment Period 4 | Consumer and Industrial Chemistry Technologies | Discontinued operations, disposed of by sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contingent liabilities remaining period		15 months
Amended terpene supply agreement
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Additional loss			$ 0.8

Discontinued Operations - Summa

Discontinued Operations - Summary Of Financial Information That Has Been Segregated From Continuing Operations (Details) - USD ($) $ in Thousands	3 Months Ended					6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net income from discontinued operations	$ 0	$ (2,425)	$ 117	$ (1,608)	$ 46,074	$ 44,466	$ 44,583	$ 42,158
Consumer and Industrial Chemistry Technologies | Discontinued Operations, Held-for-sale
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenue	0				11,031
Operating expenses	0				(11,447)
Depreciation and amortization	0				0
Research and development	0				(69)
(Loss) income from operations	0				(485)
Other income	0				35
Gain on sale of business	0				66,791
Income before income taxes	0				66,341
Income tax expense	0				(20,267)
Net income from discontinued operations	$ 0				$ 46,074

Leases - Additional Disclosure

Leases - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Jan. 01, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, renewal term	10 years
Operating lease right-of-use assets	$ 2,473	$ 16,388
Long-term operating lease liabilities	9,754	$ 16,973
Lease ROU impairment	7,400
Accounting Standards Update 2016-02
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease right-of-use assets	6,200		$ 18,400
Long-term operating lease liabilities	$ 3,400		$ 18,400
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, remaining lease term	1 year
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Operating lease, remaining lease term	10 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense and Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease expense	$ 570	$ 653
Short-term lease expense	32	43
Interest on lease liabilities	4
Total lease expense	606	696
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	584	582
Operating cash flows from finance leases	3	0
Financing cash flows from finance leases	$ (51)	$ 0

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating Leases
2020 (excluding the three months ended March 31, 2020)	$ 1,393
2021	1,957
2022	1,912
2023	1,488
2024	1,338
Thereafter	8,153
Total lease payments	16,241
Less: Interest	(5,320)
Present value of lease liabilities	10,921	$ 17,459
Finance Leases
2020 (excluding the three months ended March 31, 2020)	54
2021	71
2022	47
2023	38
2024	23
Thereafter	0
Total lease payments	233
Less: Interest	(33)
Present value of lease liabilities	$ 200	$ 213

Leases - Supplemental Balance S

Leases - Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating Leases
Operating lease right-of-use assets	$ 2,473	$ 16,388
Current portion of operating lease liabilities	1,167	486
Long-term operating lease liabilities	9,754	16,973
Total operating lease liabilities	10,921	17,459
Finance Leases
Property and equipment	293	293
Accumulated depreciation	(38)	(28)
Property and equipment, net	255	265
Current portion of finance lease liabilities	56	55
Long-term finance lease liabilities	144	158
Total finance lease liabilities	$ 200	$ 213
Weighted Average Remaining Lease Term
Operating leases	9 years 2 months 12 days	16 years 7 months 6 days
Finance leases	4 years 3 months 18 days	4 years 7 months 6 days
Weighted Average Discount Rate
Operating leases	8.90%	8.90%
Finance leases	8.50%	9.00%

Revenue from Contracts with C_3

Revenue from Contracts with Customers (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenue from Contract with Customer [Abstract]
Percentage of total revenue accounted for percentage-of-completion revenue, less than (in percentage)		0.10%
Product sales as a percentage of total revenue (in percentage)	95.00%	95.00%
Disaggregation of Revenue [Line Items]
Revenue	$ 19,416	$ 43,256
Operating expenses (excluding depreciation and amortization):	22,841	43,968
Products
Disaggregation of Revenue [Line Items]
Revenue	18,800	42,072
Operating expenses (excluding depreciation and amortization):	22,534	43,447
Services
Disaggregation of Revenue [Line Items]
Revenue	616	1,184
Operating expenses (excluding depreciation and amortization):	$ 307	$ 521

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Supplemental cash payment information:
Interest paid	$ 4	$ 578
Income taxes paid, net of refunds	$ (32)	$ 22

Inventories (Details)

Inventories (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019
Inventory Disclosure [Abstract]
Raw materials	$ 3,983,000	$ 4,339,000
Finished goods	17,287,000	24,569,000
Inventories	21,270,000	28,908,000
Less reserve for excess and obsolete inventory	(4,948,000)	(5,698,000)
Inventories, net	$ 16,322,000	$ 23,210,000	$ 25,604,000	$ 27,646	$ 35,377

Property and Equipment - Compon

Property and Equipment - Components of Property and Equipment (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Components of Property, Plant and Equipment
Property and equipment	$ 20,290	$ 77,334
Less accumulated depreciation	(12,344)	(37,505)
Property and equipment, net	7,946	39,829
Land
Components of Property, Plant and Equipment
Property and equipment	3,261	4,440
Buildings and leasehold improvements
Components of Property, Plant and Equipment
Property and equipment	6,045	38,741
Machinery and equipment
Components of Property, Plant and Equipment
Property and equipment	6,848	27,694
Fixed assets in progress
Components of Property, Plant and Equipment
Property and equipment	21	0
Furniture and fixtures
Components of Property, Plant and Equipment
Property and equipment	1,359	1,671
Transportation equipment
Components of Property, Plant and Equipment
Property and equipment	1,292	1,440
Computer equipment and software
Components of Property, Plant and Equipment
Property and equipment	$ 1,464	$ 3,348

Property and Equipment - Additi

Property and Equipment - Additional Disclosures (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 1,700,000	$ 1,800,000
Property and equipment	$ 30,200,000		$ 0

Impairment of Fixed and Long-_3

Impairment of Fixed and Long-lived Assets (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)reporting_unit
Goodwill [Line Items]
Number of reporting units | reporting_unit	1
Impairment of fixed and long lived	$ 57,500
Asset group
Goodwill [Line Items]
Impairment of fixed and long lived	$ 57,454

Impairment of Fixed and Long-_4

Impairment of Fixed and Long-lived Assets - Schedule of impairment charges (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	$ 57,500
Asset group
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	57,454
Asset group | Property and equipment, net
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	30,178
Asset group | Operating lease right-of-use assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	7,434
Asset group | Other intangible assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	19,842
Asset group | Patents | Other intangible assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	9,902
Asset group | Customer lists | Other intangible assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	9,165
Asset group | Intangibles assets in progress | Other intangible assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	596
Asset group | Trademarks and brand names | Other intangible assets
Long Lived Assets Held-for-sale [Line Items]
Impairment of fixed and long lived	$ 179

Other Intangible Assets - Sched

Other Intangible Assets - Schedule of Other Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Other intangible assets, net	$ 0	$ 20,323
Acquired Intangible Assets
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Finite-lived intangible assets, cost	0	34,211
Finite-lived intangible assets, accumulated amortization	0	13,888
Patents and technology
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Finite-lived intangible assets, cost	0	17,493
Finite-lived intangible assets, accumulated amortization	0	6,715
Customer lists
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Finite-lived intangible assets, cost	0	15,367
Finite-lived intangible assets, accumulated amortization	0	6,013
Trademarks and brand names
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Finite-lived intangible assets, cost	0	1,351
Finite-lived intangible assets, accumulated amortization	0	1,160
Intangible assets in progress
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Finite-lived intangible assets, cost	0	0
Finite-lived intangible assets, accumulated amortization	$ 0	$ 0

Other Intangible Assets - Addit

Other Intangible Assets - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Amortization of finite-lived intangible assets	$ 500	$ 500
Impairment of fixed and long lived	$ 57,500
Minimum
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Amortization period	2 years
Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	$ 57,454
Other intangible assets | Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	19,842
Patents | Other intangible assets | Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	9,902
Customer lists | Other intangible assets | Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	9,165
Intangibles assets in progress | Other intangible assets | Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	596
Trademarks and brand names | Other intangible assets | Asset group
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Impairment of fixed and long lived	$ 179

Earnings (Loss) Per Share - Add

Earnings (Loss) Per Share - Additional Disclosures (Details) - shares shares in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from calculation of earnings per share (in shares)	0.4	0.2
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities excluded from calculation of earnings per share (in shares)	3

Fair Value Measurements - Addit

Fair Value Measurements - Additional Disclosures (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 80,263	$ 100,575	$ 96,753	$ 3,044
Impairment of fixed and long lived	57,500
Government money market account
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Cash and cash equivalents	25,100	48,400
Interest bearing demand deposit account
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Cash and cash equivalents	45,900	45,700
Operating cash accounts
Assets Measured at Fair Value on a Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 9,300	$ 6,500

Income Taxes - Reconciliation o

Income Taxes - Reconciliation of Effective Tax Rate (Details)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
U.S. federal statutory tax rate	21.00%	21.00%
State income taxes, net of federal benefit	(0.10%)	0.50%
Non-U.S. income taxed at different rates	0.10%	1.30%
Reduction in tax benefit related to stock-based awards	(0.20%)	(2.30%)
Non-deductible expenses	(0.10%)	(0.60%)
Research and development credit (expense)	0.10%	0.80%
Increase in valuation allowance	(15.00%)	(18.50%)
Effect of tax rate differences of NOL carryback	3.00%	0.00%
Other	0.00%	(0.20%)
Effective income tax rate	8.80%	2.00%

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Income Tax Contingency [Line Items]
Increase (decrease) in valuation allowance		$ (4)
Valuation allowance		$ 19.9
COVID-19 pandemic
Income Tax Contingency [Line Items]
Increase (decrease) in valuation allowance	$ 4
Proceeds expected from carry back claim tax refund	6.1
Additional tax benefits	$ (2.1)

Common Stock - Reconciliation o

Common Stock - Reconciliation of Changes in Common Shares Issued and Additional Disclosures (Details)	May 05, 2020shares	Nov. 09, 2009series$ / sharesshares	Mar. 31, 2020$ / sharesshares	Dec. 31, 2019$ / sharesshares
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Common stock, shares authorized (in shares)		80,000,000	80,000,000	80,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)		100,000	100,000	100,000
Preferred stock, minimum number of series authorized (series) | series		1
Preferred stock, at par value (in dollars per share) | $ / shares		$ 0.0001	$ 0.0001	$ 0.0001
Reconciliation of changes in common shares issued
Shares issued at December 31, 2019			63,656,897
Issued as restricted stock award grants			681,190
Shares issued at March 31, 2020			64,338,087
Subsequent event
Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]
Common stock, shares authorized (in shares)	140,000,000
Common stock, number of additional shares authorized (in shares)	60,000,000

Common Stock - Stock Repurchase

Common Stock - Stock Repurchase Program (Details) - USD ($)	3 Months Ended		43 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2018	Jun. 30, 2015
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, remaining amount	$ 49,700,000
Share Repurchase Program, June 2015
Equity, Class of Treasury Stock [Line Items]
Stock repurchase program, authorized amount (up to)				$ 50,000,000
Repurchase of common stock			$ 300,000
Repurchase of common stock during period (in shares)	0	0

Business Segment, Geographic _3

Business Segment, Geographic and Major Customer Information - Additional Disclosures (Details)	3 Months Ended
	Mar. 31, 2020segment
Segment Reporting [Abstract]
Number of reportable segments (segment)	1

Business Segment, Geographic _4

Business Segment, Geographic and Major Customer Information - Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Summarized financial information regarding reportable segments
Net revenue from external customers	$ 19,416	$ 43,256
Loss from operations	(70,085)	(13,635)
Depreciation and amortization	2,191	2,260
Capital expenditures	42	461
Operating Segments | Energy Chemistry Technologies
Summarized financial information regarding reportable segments
Net revenue from external customers	19,416	43,256
Loss from operations	(70,269)	(4,703)
Depreciation and amortization	1,809	1,785
Capital expenditures	42	461
Corporate and Other
Summarized financial information regarding reportable segments
Net revenue from external customers	0	0
Loss from operations	184	(8,932)
Depreciation and amortization	382	475
Capital expenditures	$ 0	$ 0

Business Segment, Geographic _5

Business Segment, Geographic and Major Customer Information - Assets by Reportable Segments (Details) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019
Segment Reporting Information [Line Items]
Total assets	$ 136,774,000	$ 230,600,000	$ 247,868,000	$ 262,260	$ 281,051
Operating Segments | Energy Chemistry Technologies
Segment Reporting Information [Line Items]
Total assets	45,883,000	116,110,000
Corporate and Other
Segment Reporting Information [Line Items]
Total assets	90,891,000	114,490,000
Total assets
Segment Reporting Information [Line Items]
Total assets	$ 136,774,000	$ 230,600,000

Business Segment, Geographic _6

Business Segment, Geographic and Major Customer Information - Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 19,416	$ 43,256
U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	15,775	38,875
Other countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue	$ 3,641	$ 4,381

Business Segment, Geographic _7

Business Segment, Geographic and Major Customer Information - Major Customers (Details) - Customer Concentration Risk - Sales	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Customer A
Segment Reporting Information [Line Items]
Percentage of revenue by major customers	39.90%
Customer B
Segment Reporting Information [Line Items]
Percentage of revenue by major customers	17.90%	19.00%
Customer D
Segment Reporting Information [Line Items]
Percentage of revenue by major customers		12.60%

Commitments and Contingencies (

Commitments and Contingencies (Details)	Mar. 30, 2017lawsuit
Punitive Lawsuits Filed in the United States District Court for the Southern District of Texas
Loss Contingencies [Line Items]
Number of lawsuits dismissed (lawsuit)	4

Related Party Transaction (Deta

Related Party Transaction (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Sep. 30, 2019	Jun. 30, 2019
Chief Executive Officer | IRS Tax Indemnification
Related Party Transaction [Line Items]
Income taxes paid	$ 0.6
Due from related party	2.3	$ 2.4
IRS Tax Indemnification
Related Party Transaction [Line Items]
Loss contingency accrual	1.8		$ 2.4
Potential penalties and interest on IRS obligation | IRS Tax Indemnification
Related Party Transaction [Line Items]
Loss contingency accrual	$ 0.2

Revision of Prior Financial S_3

Revision of Prior Financial Statements (Details) $ in Millions	3 Months Ended
	Mar. 31, 2019USD ($)	Mar. 31, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Number of errors		2
Trademarks and brand names
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Misstatement	$ 2.8

Revision of Prior Financial S_4

Revision of Prior Financial Statements - Summary of impacted financial statements (Details) - USD ($)	3 Months Ended					6 Months Ended	9 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2019
Balance Sheet
Inventories, net	$ 16,322,000	$ 23,210,000	$ 25,604,000	$ 27,646	$ 35,377	$ 27,646	$ 25,604,000	$ 23,210,000
Other intangible assets, net	0	20,323,000	20,818,000	21,530	22,218	21,530	20,818,000	20,323,000
Total assets	136,774,000	230,600,000	247,868,000	262,260	281,051	262,260	247,868,000	230,600,000
Total Liabilities and Stockholders’ Equity	136,774,000	230,600,000	247,868,000	262,260	281,051	262,260	247,868,000	230,600,000
Income Statement
Operating expenses (excluding depreciation and amortization)	22,841,000	42,389,000	23,622,000	38,121,000	43,968,000	82,089,000	105,711,000	148,100,000
Income tax benefit (expense)	6,169,000	(956,000)	191,000	192,000	311,000	503,000	694,000	(262,000)
Loss from continuing operations	(63,967,000)	(36,896,000)	(11,160,000)	(12,805,000)	(15,212,000)	(28,017,000)	(39,177,000)	(76,073,000)
Income from discontinued operations, net of tax	0	(2,425,000)	117,000	(1,608,000)	46,074,000	44,466,000	44,583,000	42,158,000
Net (loss) income	$ (63,967,000)	(39,321,000)	(11,043,000)	(14,413,000)	30,862,000	16,449,000	5,406,000	(33,915,000)
As previously reported
Balance Sheet
Inventories, net		21,697,000	24,333,000	26,442	34,358	26,442	24,333,000	21,697,000
Other intangible assets, net		23,083,000	23,578,000	24,290	24,978	24,290	23,578,000	23,083,000
Total assets		231,847,000	249,357,000	263,816	282,792	263,816	249,357,000	231,847,000
Total Liabilities and Stockholders’ Equity		231,847,000	249,357,000	263,816	282,792	263,816	249,357,000	231,847,000
Income Statement
Operating expenses (excluding depreciation and amortization)		42,631,000	23,689,000	38,306,000	44,599,000	82,905,000	106,594,000	149,225,000
Income tax benefit (expense)		(956,000)	191,000	192,000	774,000	966,000	1,157,000	201,000
Loss from continuing operations		(37,138,000)	(11,227,000)	(12,990,000)	(15,380,000)	(28,370,000)	(39,597,000)	(76,735,000)
Income from discontinued operations, net of tax		(2,425,000)	117,000	(1,608,000)	48,372,000	46,764,000	46,881,000	44,456,000
Net (loss) income		(39,563,000)	(11,110,000)	(14,598,000)	32,992,000	18,394,000	7,284,000	(32,279,000)
Revisions
Balance Sheet
Inventories, net		1,513,000	1,271,000	1,204	1,019	1,204	1,271,000	1,513,000
Other intangible assets, net		(2,760,000)	(2,760,000)	(2,760)	(2,760)	(2,760)	(2,760,000)	(2,760,000)
Total assets		(1,247,000)	(1,489,000)	(1,556)	(1,741)	(1,556)	(1,489,000)	(1,247,000)
Total Liabilities and Stockholders’ Equity		(1,247,000)	(1,489,000)	(1,556)	(1,741)	(1,556)	(1,489,000)	(1,247,000)
Income Statement
Operating expenses (excluding depreciation and amortization)		(242,000)	(67,000)	(185,000)	(631,000)	(816,000)	(883,000)	(1,125,000)
Income tax benefit (expense)		0	0	0	(463,000)	(463,000)	(463,000)	(463,000)
Loss from continuing operations		242,000	67,000	185,000	168,000	353,000	420,000	662,000
Income from discontinued operations, net of tax		0	0	0	(2,298,000)	(2,298,000)	(2,298,000)	(2,298,000)
Net (loss) income		$ 242,000	$ 67,000	$ 185,000	$ (2,130,000)	$ (1,945,000)	$ (1,878,000)	$ (1,636,000)

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Millions	May 18, 2020	May 05, 2020	May 26, 2020	Apr. 30, 2020	Mar. 31, 2020	Dec. 31, 2019	Nov. 09, 2009
Subsequent Event [Line Items]
Common stock, shares authorized (in shares)					80,000,000	80,000,000	80,000,000
Subsequent event
Subsequent Event [Line Items]
Common stock, number of additional shares authorized (in shares)		60,000,000
Common stock, shares authorized (in shares)		140,000,000
Consideration transferred	$ 34.4
Assumption of debt	$ 1.3
COVID-19 pandemic | Subsequent event
Subsequent Event [Line Items]
CARES Act, temporary tax refund, extension to carryback provisions				$ 6.1
Loan amount				$ 4.8
Payment to terminate lease			$ 1
JP3 Measurement, LLC | Subsequent event
Subsequent Event [Line Items]
Ownership (in percentage)	100.00%